Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-02-26 @ 12:43 AM
Study NCT ID:
NCT02403869
Status:
COMPLETED
Last Update Posted:
2022-06-30
First Post:
2015-03-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy
Sponsor:
Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CEL-CMM-2013-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None